Payment overview · 2025
General Payments
$156.54
9 reported records · 5 companies
Healthcare provider profile · identity verified
Edwin P Little, MD
Allopathic & Osteopathic Physicians|Family Medicine · PINK HILL, NC · NPI 1194700799
Verified facts
What the public records show
CMS Open Payments records show Edwin P Little, MD received $156.54 in general payments during 2025 across 9 reported records.
Amgen Inc. accounted for 44.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $69.34 | 44.3% | 4 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $43.14 | 27.6% | 2 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $15.71 | 10.0% | 1 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $14.60 | 9.3% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $13.75 | 8.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $156.54 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $69.34 | 4 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $69.34 | 4 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $43.14 | 2 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $15.71 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $15.71 | 1 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $14.60 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $13.75 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 489 | 119 |
| Lisinopril | Lisinopril | 395 | 93 |
| Amlodipine Besylate | Amlodipine Besylate | 383 | 83 |
| Gabapentin | Gabapentin | 305 | 75 |
| Metformin Hcl | Metformin Hcl | 298 | 69 |
| Ezetimibe | Ezetimibe | 274 | 61 |
| Levothyroxine Sodium | Levothyroxine Sodium | 248 | 53 |
| Pantoprazole Sodium | Pantoprazole Sodium | 203 | 48 |
| Omeprazole | Omeprazole | 186 | 49 |
| Trazodone Hcl | Trazodone Hcl | 186 | 38 |
| Glimepiride | Glimepiride | 167 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 162 | 36 |
| Sertraline Hcl | Sertraline Hcl | 160 | 32 |
| Losartan Potassium | Losartan Potassium | 159 | 36 |
| Potassium Chloride | Potassium Chloride | 139 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 135 | 28 |
| Pravastatin Sodium | Pravastatin Sodium | 133 | 32 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 128 | 33 |
| Furosemide | Furosemide | 124 | 34 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 117 | 18 |
| Synthroid | Levothyroxine Sodium | 114 | 19 |
| Eliquis | Apixaban | 110 | 21 |
| Carvedilol | Carvedilol | 107 | 21 |
| Allopurinol | Allopurinol | 104 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 101 | 26 |
| Ozempic | Semaglutide | 96 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 91 | 24 |
| Bupropion Xl | Bupropion Hcl | 89 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 87 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 83 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 79 | 17 |
| Metoprolol Succinate | Metoprolol Succinate | 77 | 20 |
| Amoxicillin | Amoxicillin | 67 | 53 |
| Alendronate Sodium | Alendronate Sodium | 66 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 65 | 12 |
| Azithromycin | Azithromycin | 65 | 51 |
| Clopidogrel | Clopidogrel Bisulfate | 64 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 62 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 59 | 21 |
| Jardiance | Empagliflozin | 57 | 13 |
| Montelukast Sodium | Montelukast Sodium | 57 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 56 | 13 |
| Colchicine | Colchicine | 53 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 52 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 50 | suppressed |
| Alprazolam | Alprazolam | 48 | 11 |
| Simvastatin | Simvastatin | 48 | 11 |
| Naltrexone Hcl | Naltrexone Hcl | 46 | suppressed |
| Vascepa | Icosapent Ethyl | 45 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 43 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 42 | suppressed |
| Linzess | Linaclotide | 42 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | 15 |
| Famotidine | Famotidine | 41 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 41 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 33 |
| Atenolol | Atenolol | 39 | suppressed |
| Finasteride | Finasteride | 38 | suppressed |
| Trulicity | Dulaglutide | 38 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 37 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 35 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 34 | suppressed |
| Spironolactone | Spironolactone | 34 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 33 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 14 |
| Novolog Flexpen | Insulin Aspart | 32 | suppressed |
| Repatha Sureclick | Evolocumab | 32 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 31 | suppressed |
| Memantine Hcl | Memantine Hcl | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 30 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 29 | suppressed |
| Lamotrigine | Lamotrigine | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 29 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 28 | 13 |
| Torsemide | Torsemide | 28 | suppressed |
| Febuxostat | Febuxostat | 27 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | 14 |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Humalog | Insulin Lispro | 22 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 20 | suppressed |
| Meloxicam | Meloxicam | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 15 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Ketoconazole | Ketoconazole | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Cephalexin | Cephalexin | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Praluent Pen | Alirocumab | 12 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 12 | suppressed |
| Clonazepam | Clonazepam | 11 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $156.54 · 9 records | Amgen Inc. | CAPVAXIVE, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, GARDASIL 9, GVOKE HYPOPEN, OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error